Inhibrx Biosciences (INBX) Institutional Ownership

$92.25 -1.38 (-1.47%)

As of 12:42 PM Eastern

Current Institutional Ownership Percentage: 82.46%
Number of Institutional Buyers (last 12 months): 68
Total Institutional Inflows (last 12 months): $223.16M

Number of Institutional Sellers (last 12 months): 36
Total Institutional Outflows (last 12 months): $78.16M

Get INBX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Inhibrx Biosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

INBX Institutional Buying and Selling by Quarter

Inhibrx Biosciences Major Shareholders & Ownership History

Export

Reporting Date	Major Shareholder Name	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
5/29/2026	Perceptive Advisors LLC	1,442,707	$96.99M	1.9%	-0.7%	9.834%
5/19/2026	Bank of America Corp DE	32,683	$2.20M	0.0%	-52.7%	0.223%
5/19/2026	Janus Henderson Group PLC	3,400	$229K	0.0%	N/A	0.023%
5/16/2026	The Manufacturers Life Insurance Company	4,228	$284K	0.0%	+51.8%	0.029%
5/16/2026	Quantinno Capital Management LP	17,704	$1.19M	0.0%	+76.4%	0.121%
5/16/2026	SummitTX Capital L.P.	137,821	$9.27M	0.3%	+66.3%	0.943%
5/14/2026	Healthcare of Ontario Pension Plan Trust Fund	170,700	$11.48M	0.0%	-35.3%	1.168%
5/14/2026	Renaissance Technologies LLC	50,183	$3.37M	0.0%	-4.6%	0.343%
5/7/2026	Swiss National Bank	14,400	$968K	0.0%	N/A	0.099%
5/5/2026	Bank of New York Mellon Corp	25,874	$1.74M	0.0%	-3.3%	0.177%
Get the Latest News and Ratings for INBX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Inhibrx Biosciences and its competitors with MarketBeat's FREE daily newsletter.
5/4/2026	Empirical Financial Services LLC d.b.a. Empirical Wealth Management	22,584	$1.52M	0.0%	-1.3%	0.155%
4/27/2026	Moran Wealth Management LLC	3,163	$213K	0.0%	N/A	0.022%
4/22/2026	Janney Montgomery Scott LLC	6,406	$431K	0.0%	+16.6%	0.044%
3/9/2026	Corient Private Wealth LLC	20,443	$1.62M	0.0%	N/A	0.141%
2/19/2026	Invesco Ltd.	112,396	$8.88M	0.0%	+539.6%	0.773%
2/19/2026	Corient Private Wealth LLC	20,443	$1.62M	0.0%	N/A	0.141%
2/18/2026	XTX Topco Ltd	9,021	$713K	0.0%	N/A	0.062%
2/18/2026	Virtus Investment Advisers LLC	3,343	$264K	0.1%	N/A	0.023%
2/18/2026	Wellington Management Group LLP	28,393	$2.24M	0.0%	-4.6%	0.195%
2/18/2026	SummitTX Capital L.P.	82,885	$6.55M	0.2%	+53.1%	0.570%
2/18/2026	Tudor Investment Corp ET AL	4,642	$367K	0.0%	N/A	0.032%
2/18/2026	Perceptive Advisors LLC	1,452,707	$114.76M	2.0%	+9.4%	9.991%
2/18/2026	Millennium Management LLC	275,917	$21.80M	0.0%	-7.4%	1.898%
2/18/2026	Bridgeway Capital Management LLC	9,000	$711K	0.0%	-45.5%	0.062%
2/17/2026	Viking Global Investors LP	1,437,705	$113.58M	0.3%	-19.6%	9.888%
2/17/2026	Schonfeld Strategic Advisors LLC	214,725	$16.96M	0.1%	+120.5%	1.477%
2/17/2026	AQR Capital Management LLC	7,501	$593K	0.0%	+25.1%	0.052%
2/17/2026	Jain Global LLC	12,098	$956K	0.0%	N/A	0.083%
2/17/2026	Laird Norton Wetherby Trust Company LLC	40,382	$3.19M	0.1%	N/A	0.278%
2/17/2026	Jump Financial LLC	3,504	$277K	0.0%	N/A	0.024%
2/17/2026	Price T Rowe Associates Inc. MD	5,334	$422K	0.0%	N/A	0.037%
2/17/2026	Diadema Partners LP	1,299	$103K	0.0%	N/A	0.009%
2/17/2026	Russell Investments Group Ltd.	20,778	$1.64M	0.0%	-45.5%	0.143%
2/17/2026	Persistent Asset Partners Ltd	346	$27K	0.0%	N/A	0.002%
2/17/2026	Hurley Capital LLC	1,660	$131K	0.1%	N/A	0.011%
2/16/2026	Squarepoint Ops LLC	3,398	$268K	0.0%	N/A	0.023%
2/16/2026	Sofinnova Investments Inc.	454,657	$35.92M	1.5%	+3.3%	3.127%
2/16/2026	Mariner LLC	12,746	$1.01M	0.0%	-26.5%	0.088%
2/16/2026	Healthcare of Ontario Pension Plan Trust Fund	264,000	$20.86M	0.0%	N/A	1.816%
2/16/2026	Kennedy Capital Management LLC	71,488	$5.65M	0.1%	-55.8%	0.492%
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside) (Ad) Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top S&P 500 stock for 12 years running—and today, he's giving away his #1 AI stock pick for 2026, free. This company's sales are up 28% year over year, it holds over 30,000 patents in wireless and video technology, and it just earned an A-rating in his proprietary Stock Grader system that has cost him $9 million to build and maintain. Get the name and ticker of Louis Navellier's #1 AI stock free
2/16/2026	Barclays PLC	21,879	$1.73M	0.0%	+62.5%	0.150%
2/13/2026	Marshall Wace LLP	29,310	$2.32M	0.0%	+7.6%	0.202%
2/13/2026	The Manufacturers Life Insurance Company	2,785	$220K	0.0%	N/A	0.019%
2/13/2026	Morgan Stanley	1,167,728	$92.25M	0.0%	+163.7%	8.031%
2/13/2026	Rafferty Asset Management LLC	8,582	$678K	0.0%	N/A	0.059%
2/13/2026	Birchview Capital LP	3,698	$292K	0.2%	-88.3%	0.025%
2/13/2026	Charles Schwab Investment Management Inc.	27,341	$2.16M	0.0%	-1.6%	0.188%
2/13/2026	State Street Corp	374,961	$29.62M	0.0%	+83.9%	2.579%
2/13/2026	Wells Fargo & Company MN	10,813	$854K	0.0%	+42.3%	0.074%
2/12/2026	MetLife Investment Management LLC	5,320	$420K	0.0%	-28.4%	0.037%
2/12/2026	Groupe la Francaise	15,636	$1.24M	0.0%	-67.0%	0.108%
2/12/2026	State Board of Administration of Florida Retirement System	3,800	$300K	0.0%	N/A	0.026%
2/12/2026	Renaissance Technologies LLC	52,600	$4.16M	0.0%	+526.2%	0.362%
2/12/2026	Nuveen LLC	17,090	$1.35M	0.0%	-2.8%	0.118%
2/11/2026	Janney Montgomery Scott LLC	5,495	$434K	0.0%	N/A	0.038%
2/11/2026	Deutsche Bank AG	6,638	$524K	0.0%	N/A	0.046%
2/11/2026	Franklin Resources Inc.	29,308	$2.32M	0.0%	+70.8%	0.202%
2/11/2026	Capital Research Global Investors	421,575	$33.30M	0.0%	N/A	2.899%
2/11/2026	Daiwa Securities Group Inc.	841	$66K	0.0%	N/A	0.006%
2/10/2026	Norges Bank	133,300	$10.53M	0.0%	N/A	0.917%
2/10/2026	Intech Investment Management LLC	3,242	$256K	0.0%	N/A	0.022%
2/9/2026	Geode Capital Management LLC	226,009	$17.86M	0.0%	+1.8%	1.554%
2/9/2026	Jefferies Financial Group Inc.	8,901	$703K	0.0%	N/A	0.061%
2/6/2026	PSP Research LLC	6,389	$505K	0.4%	N/A	0.044%
2/6/2026	HighTower Advisors LLC	870,507	$68.77M	0.1%	-0.1%	5.985%
2/3/2026	Ethic Inc.	12,971	$1.03M	0.0%	-10.5%	0.089%
2/3/2026	Credit Industriel ET Commercial	8,656	$684K	0.1%	-70.1%	0.060%
2/3/2026	Mitsubishi UFJ Asset Management Co. Ltd.	3,101	$233K	0.0%	N/A	0.021%
1/29/2026	UBS Group AG	73,699	$5.82M	0.0%	+681.9%	0.507%
1/29/2026	Vanguard Group Inc.	623,084	$49.22M	0.0%	+4.7%	4.285%
1/29/2026	China Universal Asset Management Co. Ltd.	2,370	$187K	0.0%	-6.7%	0.016%
1/26/2026	Mirae Asset Global Investments Co. Ltd.	707	$56K	0.0%	+26.3%	0.005%
1/16/2026	Empirical Financial Services LLC d.b.a. Empirical Wealth Management	22,883	$1.81M	0.0%	+1.3%	0.157%
1/15/2026	Presidio Capital Management LLC	3,394	$268K	0.1%	N/A	0.023%
1/9/2026	SG Americas Securities LLC	16,088	$1.27M	0.0%	N/A	0.111%
1/1/2026	JPMorgan Chase & Co.	4,829	$163K	0.0%	-9.0%	0.033%
11/17/2025	Jacobs Levy Equity Management Inc.	13,719	$462K	0.0%	N/A	0.095%
11/17/2025	Woodline Partners LP	336,590	$11.34M	0.1%	-49.2%	2.325%
11/17/2025	Public Employees Retirement System of Ohio	1,200	$40K	0.0%	N/A	0.008%
11/17/2025	Mariner LLC	17,342	$584K	0.0%	+45.1%	0.120%
11/17/2025	Millennium Management LLC	297,820	$10.03M	0.0%	+8.0%	2.057%
11/17/2025	MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	4,130	$139K	0.0%	-16.6%	0.029%
11/17/2025	HighVista Strategies LLC	7,626	$257K	0.1%	N/A	0.053%
11/17/2025	Citadel Advisors LLC	57,194	$1.93M	0.0%	N/A	0.395%
11/17/2025	Bank of America Corp DE	17,832	$601K	0.0%	+95.3%	0.123%
11/17/2025	Boothbay Fund Management LLC	78,812	$2.65M	0.0%	+179.2%	0.544%
11/17/2025	ArrowMark Colorado Holdings LLC	35,176	$1.19M	0.0%	-2.8%	0.243%
11/17/2025	Alliancebernstein L.P.	19,230	$648K	0.0%	-5.8%	0.133%
11/14/2025	Schonfeld Strategic Advisors LLC	97,382	$3.28M	0.0%	-37.1%	0.673%
11/14/2025	SummitTX Capital L.P.	54,143	$1.82M	0.1%	N/A	0.374%
Before you buy SpaceX shares, consider this alternative approach (Ad) SpaceX has confidentially filed for an IPO with the SEC, targeting a June 2026 listing at a valuation exceeding $1.75 trillion - potentially the largest IPO in history. But one expert says buying shares directly may not be the smartest move. There is a lesser-known way to tap into this windfall that most investors haven't considered. Discover the overlooked SpaceX IPO strategy before the June listing
11/14/2025	Caligan Partners LP	236,383	$7.96M	1.0%	N/A	1.632%
11/14/2025	Acuta Capital Partners LLC	16,377	$552K	0.6%	N/A	0.113%
11/14/2025	Slotnik Capital LLC	41,401	$1.39M	0.4%	-77.5%	0.286%
11/13/2025	Kennedy Capital Management LLC	161,909	$5.45M	0.1%	-8.7%	1.118%
11/13/2025	Arrowstreet Capital Limited Partnership	6,003	$202K	0.0%	N/A	0.041%
11/13/2025	BNP Paribas Financial Markets	1,886	$64K	0.0%	+71.9%	0.013%
11/13/2025	Franklin Resources Inc.	17,164	$578K	0.0%	-22.6%	0.119%
11/13/2025	Russell Investments Group Ltd.	38,134	$1.28M	0.0%	+27.1%	0.263%
11/13/2025	Dynamic Technology Lab Private Ltd	7,388	$249K	0.0%	N/A	0.051%
11/10/2025	China Universal Asset Management Co. Ltd.	2,539	$86K	0.0%	-12.7%	0.018%

INBX Institutional Ownership - Frequently Asked Questions

During the previous two years, 114 institutional investors and hedge funds held shares of Inhibrx Biosciences. The most heavily invested institutionals were Viking Global Investors LP ($113.58M), Perceptive Advisors LLC ($96.99M), Morgan Stanley ($92.25M), HighTower Advisors LLC ($68.77M), Vanguard Group Inc. ($49.22M), Sofinnova Investments Inc. ($35.92M), and Capital Research Global Investors ($33.30M).Learn more on Inhibrx Biosciences' institutional investors.

82.46% of Inhibrx Biosciences' stock is owned by institutional investors. Learn more on INBX's institutional investor holdings.

Of the 110 institutional investors that purchased Inhibrx Biosciences' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Sanofi ($1.16M), HighTower Advisors LLC ($871.75K), Morgan Stanley ($724.87K), Walleye Capital LLC ($580.00K), Capital Research Global Investors ($421.58K), Slotnik Capital LLC ($388K), and Woodline Partners LP ($358.44K).

Institutional investors have bought a total of 3,296,297 shares in the last 24 months. This purchase volume represents approximately $223.16M in transactions.

Of the 36 institutional investors that sold Inhibrx Biosciences' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Viking Global Investors LP ($350K), Woodline Partners LP ($326.28K), Slotnik Capital LLC ($142.77K), Kennedy Capital Management LLC ($105.83K), Perceptive Advisors LLC ($96.13K), Healthcare of Ontario Pension Plan Trust Fund ($93.30K), and Schonfeld Strategic Advisors LLC ($57.41K).

Institutional investors have sold a total of 1,513,973 shares in the last 24 months. This volume of shares sold represents approximately $78.16M in transactions.

Related Companies

This page (NASDAQ:INBX) was last updated on 6/3/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Inhibrx Biosciences (INBX) Institutional Ownership

INBX Institutional Buying and Selling by Quarter

Inhibrx Biosciences Major Shareholders & Ownership History

INBX Institutional Ownership - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Inhibrx Biosciences (INBX) Institutional Ownership

Institutional Ownership Changes (13F Filings) for Inhibrx Biosciences (NASDAQ:INBX)

INBX Institutional Buying and Selling by Quarter

Inhibrx Biosciences Major Shareholders & Ownership History

INBX Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of INBX shares?

What percentage of Inhibrx Biosciences' stock is owned by institutional investors?

Which institutional investors have been buying Inhibrx Biosciences' stock?

How much institutional buying is happening at Inhibrx Biosciences?

Which of Inhibrx Biosciences' major shareholders have been selling company stock?

How much institutional selling is happening at Inhibrx Biosciences?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools